Takeda Pharmaceutical Co Ltd ADR (TAK) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $18.52
• Market Cap: $58.79B
• P/E Ratio: 80.91
• EPS: $0.23
• Dividend Yield: 0.04%
• 52-Week High: $18.82
• 52-Week Low: $12.99

Market Sentiment

Takeda Pharmaceutical Co Ltd ADR currently has a Bullish sentiment score of 0.26.

About Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited (Ticker: TAK) is a leading global biopharmaceutical firm headquartered in Tokyo, Japan, specializing in the research, development, manufacturing, and marketing of innovative pharmaceuticals and healthcare products. With a strong focus on areas such as oncology, gastroenterology, and neuroscience, Takeda leverages its advanced scientific capabilities to drive growth and deliver transformative therapies that address unmet medical needs. The company is commi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Takeda Pharmaceutical Co Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is TAK's current dividend yield?

Takeda Pharmaceutical Co Ltd ADR (TAK) has a current dividend yield of 0.04%.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Co Ltd ADR pays dividends with a current yield of 0.04%.

What is TAK's P/E ratio?

Takeda Pharmaceutical Co Ltd ADR has a price-to-earnings (P/E) ratio of 80.91.

What is TAK's market cap?

Takeda Pharmaceutical Co Ltd ADR (TAK) has a market capitalization of $58.79B with a current stock price of $18.52.